Condition
Neoplastic Processes
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 1 (1)
P 2 (1)
Trial Status
Completed2
Terminated1
Withdrawn1
Active Not Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03694015Not ApplicableTerminated
SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases
NCT03510104Phase 1Completed
Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors
NCT05884593Not ApplicableActive Not Recruiting
Analysis of Pedicle Screw Accuracy to Plan Using Medtronic Mazor Robotic System
NCT01594892Not ApplicableCompleted
Fractionated Radiosurgery for Painful Spinal Metastases
NCT01178151Phase 2Withdrawn
Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome
Showing all 5 trials